🔗 Share this article

Treasury head Reeves has announced she is preparing "targeted action to tackle household expense pressures" in the upcoming financial statement.

Speaking to media outlets, she emphasized that reducing inflation is a shared responsibility of both the government and the central bank.

The UK's price growth is forecast to be the highest among the G7 advanced economies this calendar year and next.

Possible Utility Bill Interventions

Sources suggest the government could take action to lower utility costs, for example by slashing the present 5% rate of VAT applied on energy.

Another approach is to cut some of the government charges presently included in bills.

Fiscal Limitations and Analyst Predictions

The administration will obtain the latest assessment from the official forecaster, the Office for Budget Responsibility, on Monday, which will reveal how much space there is for such actions.

The view from most analysts is that Reeves will have to declare tax rises or budget cuts in order to adhere to her self-imposed fiscal targets.

Earlier on the same day, calculations showed there was a twenty-two billion pound gap for the Treasury chief to resolve, which is at the lower end of projections.

"It is a shared task between the Bank of England and the administration to bear down further on some of the sources of price increases," the Chancellor stated to the BBC in Washington, at the yearly gatherings of the International Monetary Fund and global financial institution.

Revenue Commitments and International Issues

While much of the focus has been on probable tax increases, the chancellor said the latest information from the fiscal watchdog had not changed her commitment to manifesto promises not to increase tax levels on earnings tax, VAT or social security contributions.

She blamed an "uncertain world" with growing international and trade issues for the Budget revenue measures, probably to be focused on those "with the broadest shoulders."

International Economic Tensions

Addressing worries about the UK's trade ties with the Asian nation she said: "Our security interests invariably take priority."

Recent statement by China to tighten trade restrictions on critical minerals and other materials that are essential for advanced tech manufacturing led American leader Donald Trump to threaten an further 100% import tax on goods from the Asian country, raising the risk of an all-out commercial conflict between the two global powers.

The American finance chief described China's action "economic coercion" and "a global supply chain power grab."

Inquired about accepting the US offer to participate in its conflict with the Asian nation, Reeves said she was "very concerned" by Chinese actions and encouraged the Chinese government "not to put up barriers and limit trade."

She said the decision was "harmful for the international commerce and generates further headwinds."

"It is my opinion there are sectors where we should address China, but there are also valuable prospects to trade with Chinese markets, including banking sector and other areas of the economy. We've got to maintain that equilibrium correct."

The Treasury chief also confirmed she was working with international partners "regarding our own essential resources strategy, so that we are less reliant."

NHS Drug Pricing and Funding

The Chancellor also recognized that the price the NHS spends on medicines could rise as a consequence of current negotiations with the US government and its pharmaceutical firms, in return for lower tariffs and investment.

A number of the biggest global pharmaceutical manufacturers have said in recent statements that they are either pausing or scrapping investments in the United Kingdom, with several attributing the insufficient payments they are getting.

Last month, the Science Minister said the cost the health service spends on drugs would have to increase to prevent companies and drug research funding leaving the United Kingdom.

The Chancellor told media: "It has been observed as a result of the pricing regime, that medical research, new drugs have not been available in the UK in the manner that they are in other continental states."

"Our aim is to ensure that patients getting treatment from the NHS are can obtain the finest critical treatments in the globe. And so we are reviewing all of that, and... looking to attract increased investment into Britain."